BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/6/2023 12:22:17 PM | Browse: 203 | Download: 823
 |
Received |
|
2022-10-24 07:00 |
|
Peer-Review Started |
|
2022-10-24 07:03 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-12-12 03:36 |
|
Revised |
|
2022-12-17 07:07 |
|
Second Decision |
|
2023-01-16 03:46 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2023-01-17 06:39 |
|
Articles in Press |
|
2023-01-17 06:39 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-01-28 11:00 |
|
Publish the Manuscript Online |
|
2023-02-06 12:22 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Clinical Trials Study |
| Article Title |
Efficacy of dexamethasone and N-acetylcysteine combination in preventing post-embolization syndrome after transarterial chemoembolization in hepatocellular carcinoma
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Nitipon Simasingha, Wasu Tanasoontrarat, Torpong Claimon and Supatsri Sethasine |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Navamindradhiraj University Research Fund and the Faculty of Medicine Vajira Hospital, Navamindradhiraj University |
93/2564 |
|
| Corresponding Author |
Supatsri Sethasine, MD, Associate Professor, Chief Doctor, Department of Internal Medicine, Navamindradhiraj University, Vajira Hospital Dusit Thailand, Bangkok 10300, Thailand. supatsri@nmu.ac.th |
| Key Words |
Hepatocellular carcinoma; Post-embolization syndrome; Transarterial chemoembolization; Liver decompensation |
| Core Tip |
Conventional transarterial chemoembolization (TACE) is the current standard treatment for intermediate-stage hepatocellular carcinoma (HCC). A combination of N-acetylcysteine and dexamethasone ameliorated the occurrence of post-embolization syndrome event after TACE in patients with intermediate-stage HCC. A dynamic change in Albumin-Bilirubin score of more than 0.5 point was found to be a risk factor for post-TACE liver decompensation. |
| Publish Date |
2023-02-06 12:22 |
| Citation |
Simasingha N, Tanasoontrarat W, Claimon T, Sethasine S. Efficacy of dexamethasone and N-acetylcysteine combination in preventing post-embolization syndrome after transarterial chemoembolization in hepatocellular carcinoma. World J Gastroenterol 2023; 29(5): 890-903 |
| URL |
https://www.wjgnet.com/1007-9327/full/v29/i5/890.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v29.i5.890 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
